Advisory Research Inc Twist Bioscience Corp Transaction History

Advisory Research Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$15.08 - $38.61 $386,093 - $988,531	25,603 Added 246.7%	35,981 $1.33 Million
Q3 2023 Nov 13, 2023	SELL	$18.62 - $26.57 $200,071 - $285,494	-10,745 Reduced 50.87%	10,378 $210,000
Q2 2023 Aug 14, 2023	BUY	$11.49 - $20.46 $242,703 - $432,176	21,123 New	21,123 $432,000
Q2 2022 Aug 17, 2022	BUY	$26.2 - $54.0 $355,062 - $731,808	13,552 New	13,552 $473,000
Q2 2021 Aug 16, 2021	SELL	$88.13 - $142.06 $765,849 - $1.23 Million	-8,690 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$105.48 - $207.97 $467,381 - $921,515	4,431 Added 104.04%	8,690 $1.08 Million
Q4 2020 Feb 12, 2021	SELL	$76.64 - $167.89 $456,391 - $999,784	-5,955 Reduced 58.3%	4,259 $602,000
Q3 2020 Nov 12, 2020	SELL	$45.46 - $78.79 $735,451 - $1.27 Million	-16,178 Reduced 61.3%	10,214 $776,000
Q2 2020 Aug 13, 2020	BUY	$26.4 - $45.3 $128,488 - $220,475	4,867 Added 22.61%	26,392 $1.2 Million
Q1 2020 May 12, 2020	BUY	$19.71 - $35.15 $424,257 - $756,603	21,525 New	21,525 $658,000
Q4 2019 Feb 11, 2020	SELL	$21.0 - $26.48 $333,417 - $420,422	-15,877 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$23.72 - $33.99 $376,602 - $539,659	15,877 New	15,877 $379,000

270

67.2M

118K

40.2K

Ticker TWST
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 56,363,500
Market Cap $2.7B
Description
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...

Get notified when there are updates to the investment portfolio of Advisory Research Inc, based on Form 13F filings with the SEC.

Stay updated on Advisory Research Inc with notifications on news.